Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study

BACKGROUND: Psoriasis imposes a disease burden that can have a profound negative impact on patients' quality of life (QoL). HOPE was the first non‐interventional study conducted in patients with severe chronic plaque psoriasis in Australia that evaluated health‐related QoL in response to treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Foley, Peter, Spelman, Lynda, Murrell, Dedee F., Mate, Eric, Tronnberg, Rebecca, Lowe, Patricia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542143/
https://www.ncbi.nlm.nih.gov/pubmed/35816576
http://dx.doi.org/10.1111/ajd.13893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542143/
https://www.ncbi.nlm.nih.gov/pubmed/35816576
http://dx.doi.org/10.1111/ajd.13893

Ejemplares similares